Phase I Study to Evaluate the Safety and Efficacy of Telomelysin (OBP-301) in Patients With Hepatocellular Carcinoma
Clinical trial NCT02293850 · UNKNOWN
Trial details
- NCT number
- NCT02293850
- Sponsor
- Oncolys BioPharma Inc
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-10-01
- Primary completion
- 2019-04-01
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.